Programming the fate of medicines: An eco-by-design strategy for zero pharmaceutical residues

Pharmaceutical residues are a serious threat to the environment, biodiversity, and human health. Traditional pharmaceutical research & development is inherently unsustainable, as it does not consider the environmental impact of drug design, synthesis, packaging, and disposal. The proposed solutions, Eco‑by‑Design Pharmaceuticals and Programming the Fate of Medicines, address the issue from multiple angles. At the molecular level, the design utilizes cleavable linkers that are stable in the shelf-life of the drug but are easily degraded in water, thus minimizing the environmental footprint. Green chemistry approaches, including catalysis, mechanochemistry, continuous flow, and solvent recycling, help reduce the ecological impact of drug synthesis. The use of chitosan, cellulose nanocrystal composites in packaging reduces plastic waste and ensures the stability of the drug during transportation. Finally, the use of biochar beds made from agricultural waste to trap and detoxify pharmaceutical residues is an excellent example of a sustainable end-of-life solution.